Published by Benjamin Chiou on 9th November 2026
(Sharecast News) - Shares in AIM-listed RUA Life Sciences tumbled on Monday after the medical devices group reported weaker-than-expected trading at its French subsidiary Abiss, despite forecasting higher annual revenues and a return to profitability.
URL: http://www.digitallook.com/dl/news/story/36337697/...